Everyday life for the more than 46 million people around the world who suffer from type 1 diabetes could become much easier and safer.
Researchers from the University of Copenhagen and biotech firm Gubra have developed a new insulin molecule that, in the future, will ensure that diabetics receive just the right amount of insulin.
The insulin on the market today is unable to identify whether a patient with type 1 diabetes needs a small or large effect from the insulin, which lowers blood sugar.
Psoriasis has always been a common disease. Historically, its causes were obscure and surrounded by stigma; it wasn't until recently that scientists categorized it as an autoimmune condition. Indeed, modern scientific research shows that the body's own T-cells, macrophages and dendritic cells are responsible for attacking healthy skin tissue, triggering inflammation and proliferation of skin cells, and resulting in the characteristic red, painful plaque-like lesions experienced by psoriasis patients.
A new study suggests that COVID-19 guidance in Sweden may have reduced people's risks of having a heart attack.
By using anonymous location data from mobile phones, researchers developed an aggregate picture of the activities of the Swedish population and mapped it against attendances at the country's 29 emergency cardiac angiography units.
Cardiac angiography is used to treat blockages to the heart's blood vessels.
The evidence for the harmful effects of alcohol on brain health is compelling, but now experts have pin-pointed three key time periods in life when the effects of alcohol are likely to be at their greatest.
Writing in The BMJ today, researchers in Australia and the UK say evidence suggests three periods of dynamic brain changes that may be particularly sensitive to the harmful effects of alcohol: gestation (from conception to birth), later adolescence (15-19 years), and older adulthood (over 65 years).
Trained dogs are incredible chemical sensors, far better at detecting explosives, narcotics and other substances than even the most advanced technological device. But one challenge is that dogs have to be trained, and training them with real hazardous substances can be inconvenient and dangerous.
ATLANTA--Treatment of SARS-CoV-2 infection with a new antiviral drug, MK-4482/EIDD-2801 or Molnupiravir, completely suppresses virus transmission within 24 hours, researchers in the Institute for Biomedical Sciences at Georgia State University have discovered.
The group led by Dr. Richard Plemper, Distinguished University Professor at Georgia State, originally discovered that the drug is potent against influenza viruses.
What makes the elderly and people with underlying conditions more vulnerable to COVID-19? According to a new study led by McGill University researchers, clues can be found in the proteins involved in initiating infection, as the virus binds to host cells of different animals. Greater cellular oxidation with aging and sickness may explain why seniors and people with chronic illness get infected more often and more severely.
DALLAS - Dec. 3, 2020 - A team led by UT Southwestern has derived a new "intermediate" embryonic stem cell type from multiple species that can contribute to chimeras and create precursors to sperm and eggs in a culture dish.
The findings, published online this week in Cell Stem Cell, could lead to a host of advances in basic biology, regenerative medicine, and reproductive technology.
A person's genetic make-up can influence whether they might experience side effects from certain medications. Some laboratories now offer pharmacogenetic tests that allow patients to learn whether they carry genetic variants known to be associated with adverse drug effects. Such tests might help patients and their doctors choose safer, more effective treatments, but the U.S. Food & Drug Administration and other regulatory agencies have expressed concern that patients might make unproven, inappropriate decisions about their medications based on their pharmacogenetic results.
In the spring, scientists throughout the world were actively discussing whether there is a connection between vaccination against tuberculosis in early childhood and the mild course of the new coronavirus disease. However, at that time, statistics on patients with COVID-19 were still insufficient to draw reliable conclusions. Medical doctors throughout the world are currently beginning to find important patterns that will help protect public
health in the future.
DANVILLE, Pa. - Using a single ventilator to support two patients could be feasible in crisis situations involving a ventilator shortage, researchers have found.
A team of clinical investigators from Geisinger partnered with Bucknell University and Kitware, a New York-based software research and development company, to develop a computational model to simulate varying scenarios in which two patients share one ventilator.
New research has found that Chicago neighborhoods with barriers to social distancing, including limited access to broadband internet and low rates of health insurance, had more COVID-19 deaths in spring 2020. The study, led by researchers at the University of Illinois Chicago, is published in the Annals of Epidemiology.
TORONTO, Dec. 03, 2020 -- Most countries are not fulfilling their international legal obligations during COVID-19 and other public health emergencies, reveals new research by a consortium of 13 leading global health law scholars, hosted by the Global Strategy Lab (GSL) at York University.
When Terrie Williams began hearing about the wide range of symptoms experienced by patients with COVID-19, she saw a connection between the various ways the disease is affecting people and the many physiological adaptations that have enabled marine mammals to tolerate low oxygen levels during dives.
Williams, a professor of ecology and evolutionary biology at UC Santa Cruz, has spent decades studying the physiology of marine mammals and their extraordinary ability to perform strenuous activities while holding their breath for long periods under water.
SALT LAKE CITY - Researchers at Huntsman Cancer Institute (HCI) at the University of Utah (U of U) have identified a potential drug combination to treat uveal melanoma, a type of eye cancer. Lead author Amanda Truong, trainee in the McMahon Lab at HCI and student at the U of U, explains uveal melanoma patients frequently have changes in genes called GNAQ and GNA11, which are key targets for these drugs. This study was published in the journal Clinical Cancer Research.